[artículo] 
inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 433-441

Título :	Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation
Tipo de documento:	texto impreso
Autores:	Stephen R. Marder, Autor ; Sebastian Sorsaburu, Autor ; Eduardo Dunayevich, Autor
Fecha de publicación:	2022
Artículo en la página:	pp. 433-441
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Agitación psicomotora, Esquizofrenia.
Resumen:	Agitation is a medical emergency with increased risk for poor outcome. Successful treatment often requires intramuscular (IM) psychotropics. Safety data from the first 21 months of olanzapine IM, approved in the United States for the treatment of agitation associated with schizophrenia and bipolar disorder, are presented.
Link:	./index.php?lvl=notice_display&id=28171

[artículo] Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation [texto impreso] / Stephen R. Marder, Autor ; Sebastian Sorsaburu, Autor ; Eduardo Dunayevich, Autor . - 2022 . - pp. 433-441.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 4 (Abril) . - pp. 433-441

Palabras clave:	Antipsicóticos, Benzodiazepinas, Trastorno bipolar, Agitación psicomotora, Esquizofrenia.
Resumen:	Agitation is a medical emergency with increased risk for poor outcome. Successful treatment often requires intramuscular (IM) psychotropics. Safety data from the first 21 months of olanzapine IM, approved in the United States for the treatment of agitation associated with schizophrenia and bipolar disorder, are presented.
Link:	./index.php?lvl=notice_display&id=28171